Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Gaitatzis, A."'
Autor:
Leigh C. Ward, Katrina Gaitatzis, Belinda Thompson, Vincent Singh Paramanandam, Louise A. Koelmeyer
Publikováno v:
European Journal of Breast Health, Vol 20, Iss 4, Pp 251-257 (2024)
Objective: Breast cancer-related lymphedema (BCRL) is a common complication of breast cancer treatment that may result in swelling of the affected arm due to compromised lymphatic function. Implementing a screening program and early intervention for
Externí odkaz:
https://doaj.org/article/528662fba1fa47bf8902358391bbcba6
Autor:
Ward, Leigh C.1,2, Gaitatzis, Katrina1 katrina.gaitatzis@mq.edu.au, Thompson, Belinda1, Paramanandam, Vincent Singh1, Koelmeyer, Louise A.1
Publikováno v:
European Journal of Breast Health. Oct2024, Vol. 20 Issue 4, p251-257. 7p.
Publikováno v:
European Journal of Breast Health, Vol 20, Iss 2, Pp 141-148 (2024)
Objective: Breast cancer related lymphedema (BCRL) may be assessed through objective measurement of limb swelling with common techniques including volumetric measurement using a tape measure or perometry, and measurement of extracellular water using
Externí odkaz:
https://doaj.org/article/6a3b01be79a149de948dbd73369342b3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gaitatzis, Athanasios, Majeed, Azeem
Publikováno v:
In Seizure: European Journal of Epilepsy April 2023 107:136-145
Publikováno v:
IEEE Transactions on Neural Systems and Rehabilitation Engineering, Vol 30, Pp 2960-2969 (2022)
Medically oriented Brain Computer Interfaces (BCIs) have been proposed as a promising approach addressed to individuals suffering from severe paralysis. Steady-State Visual Evoked Potentials (SSVEPs) in particular have been proven successful in many
Externí odkaz:
https://doaj.org/article/e89e9fe873ad4b178a6fb012fa7512b9
Publikováno v:
European Journal of Breast Health; Apr2024, Vol. 20 Issue 2, p141-148, 8p
Publikováno v:
Lymphatic Research & Biology; Feb2024, Vol. 22 Issue 1, p43-54, 12p
Autor:
Alessia Biolchi, Sara Tomei, Laura Santini, Jo Anne Welsch, Daniela Toneatto, Nikolaos Gaitatzis, Xilian Bai, Ray Borrow, Marzia Monica Giuliani, Elena Mori, Mariagrazia Pizza
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 3, Pp 725-731 (2019)
The 4-component vaccine 4CMenB, developed against invasive disease caused by meningococcal serogroup B, is approved for use in infants in several countries worldwide. 4CMenB is mostly used as 3 + 1 schedule, except for the UK, where a 2 + 1 schedule
Externí odkaz:
https://doaj.org/article/3da12b18634a4ff29ee181ae95f892b7
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2001 Sep . 98(20), 11136-11141.
Externí odkaz:
https://www.jstor.org/stable/3056681